Danielle Cañas

Senior Associate Director, Recruiting Operations

Danielle Cañas

Danielle Canas (she/her) joined MIT Sloan in 2009, as the Recruiting Coordinator on the Employer Relations & Recruiting Team.  After managing many industry sectors for several years, she has transitioned to overseeing  Operations for the Employer Relations & Recruiting team, including communications to students and employers, events and special projects.

Prior to MIT Sloan, Danielle was at the Kogod School of Business at American University working in Undergraduate Programs and Academic Affairs.  Danielle started her career at Fidelity Investments in HR Operations and the Defined Contributions Group.  Since 2011, Danielle has been an active member of MBA CSEA, which is a global alliance of graduate business career management professionals and employers.  As part of MBA CSEA, she has served on the Board of Directors, co-chaired the 2017 Global Conference and led several other committees within the organization. She graduated from Saint Anselm College with a BA in Sociology.

Danielle and her husband just welcomed their first son in 2020, although their boxer, Kala, has been calling them Mom and Dad for 12 years now.  As part of a mixed race family, Danielle is trying to improve her Spanish-speaking skills, to keep up with her son and her husband.  Danielle loves to cook and read and also enjoys more TV shows than her DVR can hold.  As a family, they enjoy taking walks, traveling and gathering with family and friends.  They are hoping to take some local trips this year and introducing their son to all New England has to offer.

Contact Danielle for:

  • Recruiting Operations
  • Recruiting Events
  • Employer Advisory Council inquiries
  • Employer & Student Recruiting Communications

CDO Liaison to the Hispanic Business Club, the Brazilian Club and the Mindfulness & Leadership Club

Top 5 Strengths: Empathy, Harmony, Positivity, Consistency, Adaptability

All Posts

BioSpace – Frequency Therapeutics Completes $62 Million Series C Financing

Frequency Therapeutics, a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases, today announced the closing of a $62.0 million Series C financing. Frequency will use …

By Danielle Cañas
Danielle Cañas Senior Associate Director, Recruiting Operations Danielle Cañas
Read more »